EGFR and malignant pleural mesothelioma: The activity of a miR-16 mimic delivered by bacterial minicells targeted to EGFR (TargomiRs) was then evaluated in a phase 1 study of patients with recurrent malignant pleural mesothelioma, showing a partial response in one out of 22 evaluable patients [47, 48].